Kiniksa Pharmaceuticals, Ltd. - KNSA

SEC FilingsOur KNSA Tweets

About Gravity Analytica

Recent News

  • 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.05.2025 - Jefferies 2025 Global Healthcare Conference
  • 06.05.2025 - Jefferies 2025 Global Healthcare Conference
  • 06.05.2025 - Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis
  • 06.05.2025 - Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis
  • 06.05.2025 - Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis
  • 05.29.2025 - Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
  • 05.29.2025 - Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
  • 05.29.2025 - Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Recent Filings

  • 06.03.2025 - 8-K Current report
  • 06.03.2025 - 144 Report of proposed sale of securities
  • 06.03.2025 - 144 Report of proposed sale of securities
  • 06.03.2025 - 144 Report of proposed sale of securities
  • 05.28.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.21.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.19.2025 - 144 Report of proposed sale of securities
  • 05.15.2025 - 4 Statement of changes in beneficial ownership of securities